CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Allergan plc Company Snapshot
Allergan plc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Allergan plc with three other companies in this sector in the United States: Takeda Pharmaceutical Company Limited (2018 sales of $16.01 billion of which 96% was Pharmaceutical Business), Celgene Corporation ($15.28 billion of which 100% was Biopharmaceuticals), and Novo Nordisk As ($17.68 billion of which 84% was Diabetes and obesity).

Sales Analysis. Allergan plc reported sales of $15.79 billion for the year ending December of 2018. This represents a decrease of 1.0% versus 2017, when the company's sales were $15.94 billion. Contributing to the drop in overall sales was the 8.2% decline in Us General Medicine, from $5.80 billion to $5.32 billion. . However, these declines were partially offset by the increase in sales of Us Specialized Therapeutics (up 1.7% to $6.92 billion) and International (up 5.6% to $3.50 billion) and Other (up 84.6% to $39.50 million) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Allergan plc
  Stock Performance Chart for Allergan plc
 
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 184.94
(Figures in U.S. Dollars)
1 Week 0.6%   13 Weeks 3.7%  
4 Weeks 15.8%   52 Weeks 18.1%  
 
Allergan plc Key Data:
  Ticker: AGN Country: Ireland
  Exchanges: NYSE FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 15,787,400,000
(Year Ending Jan 2019).
Employees: 16,900
  Currency: U.S. Dollars Market Cap: 60,678,814,000
  Fiscal Yr Ends: December Shares Outstanding: 328,100,000
  Share Type: Common Closely Held Shares: 903,743
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.